Chief Medical Officer
President of Clinical Research, Regulatory, and Safety
Sorrento Therapeutics

Before joining Sorrento Therapeutics, Zeldis was CEO of Celgene Global Health and Chief Medical Officer of Celgene Corporation, Summit, NJ. Prior to that, he was Celgene’s SVP of Clinical Research and Medical Affairs and has been at Celgene since February, 1997. He attended Brown University for an AB, MS, followed by Yale University for an MPhil, MD, PhD in molecular biophysics and biochemistry (immunochemistry).

Dr. Zeldis trained in Internal Medicine at the UCLA Center for the Health Sciences and Gastroenterology at the Massachusetts General Hospital and Harvard Medical School. He was Assistant Professor of Medicine at the Harvard Medical School, Associate Professor of Medicine at University of California, Davis, Clinical Associate Professor of Medicine at Cornell Medical School and Professor of Clinical Medicine at the Robert Wood Johnson Medical School in New Brunswick, New Jersey.

Prior to working at Celgene, Dr. Zeldis worked at Sandoz Research Institute and Janssen Research Institute in both clinical research and medical development. He has been a board member of a few start-up biotechnology companies and is currently on the boards of the Semorex Corporation, PTC Corporation, Soligenix, Trek Therapeutics, and BionorPharma. He has published 122 peer-reviewed articles and 43 US patents.